PTH and chronic kidney disease: Increased levels of PTH are also associated with abnormal osteoblastic function and osteocyte stimulation with the receptor activator of NF-κB (RANK) ligand (RANK-L) leading to CKD mineralization defects, high bone turnover ROD, and bone resorption [46].